The risk of developing cardiovascular disease is strongly associated with the "bad" LDL cholesterol. A large study by scientists at Karolinska Institutet now shows that two proteins that transport cholesterol particles in ...
Dec 1, 2021
0
123
About 10 percent of patients hospitalized in Australia and New Zealand with peripheral arterial disease (PAD) unexpectedly return to hospital within 30 days, often for potentially preventable reasons, according to research ...
Nov 29, 2021
0
1
(HealthDay)—Sensitivities and negative predictive values (NPVs) are higher for the 2020 European Society of Cardiology (ESC) 0/1-hour and 0/2-hour algorithms than the 0/3-hour algorithm for high-sensitivity cardiac troponin ...
Nov 23, 2021
0
1
(HealthDay)—For patients with myocardial infarction, sacubitril-valsartan is not associated with a reduced incidence of death from cardiovascular causes or incident heart failure compared with ramipril, according to a study ...
Nov 22, 2021
0
1
Patients who earn less than $38,000 per year, identify as male or were treated in an urban hospital have a higher risk of being readmitted to a hospital within a month of discharge, according to a new University at Buffalo ...
Nov 18, 2021
0
59
Patients not only have to fight their diseases but also must deal with the pain—the more severe the condition, the more painful the injections. Recently, new doors have opened to relieve patients of these burdens. A POSTECH ...
Nov 11, 2021
0
14
(HealthDay)—Among patients with ST-segment elevation myocardial infarction (STEMI), a concomitant diagnosis of COVID-19 is associated with significantly higher rates of in-hospital mortality, according to a study published ...
Nov 8, 2021
0
17
The death of a child is an extremely stressful life event with potential long-term health consequences. The death of an offspring is associated with an increased risk of ischemic heart diseases in parents. This is according ...
Nov 4, 2021
0
4
Researchers Prof. Judith Haendeler from the Medical Faculty and the molecular biologist Prof. Joachim Altschmied from the Department of Biology, together with their teams, have shown for the first time in the cardiovascular ...
Oct 27, 2021
0
0
(HealthDay)—Compared with placebo, neither aspirin nor apixaban reduces the rate of major adverse cardiovascular or pulmonary outcomes for clinically stable outpatients with symptomatic COVID-19, according to a study published ...
Oct 18, 2021
0
16
